Get started
Novartis AGNovartis AGNovartis AG

Novartis AG

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFsBonds
Full chart
Full chart

Compare with Novartis AG



Key stats


Market capitalization
‪231.75 B‬ EUR
Dividend yield (indicated)
3.05%
Price to earnings Ratio (TTM)
22.91
Basic EPS (TTM)
5.73 EUR
Net income (FY)
‪12.47 B‬ EUR
Revenue (FY)
‪48.64 B‬ EUR
Shares float
‪1.61 B‬
Beta (1Y)
0.56

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪75.27 K‬
Change (1Y)
−616−0.81%
Revenue / Employee (1Y)
‪646.21 K‬ EUR
Net income / Employee (1Y)
‪165.71 K‬ EUR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
IPO date
May 7, 2001
ISIN
CH0012005267
FIGI
BBG00FZMF271
Identifiers
ISIN CH0012005267
CFI code
ESVTFR
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.249% YTM
Maturity dateMar 18, 2056
Coupon5.70% (Fixed)
6.217% YTM
Maturity dateNov 5, 2055
Coupon5.30% (Fixed)
6.215% YTM
Maturity dateMar 18, 2046
Coupon5.60% (Fixed)
6.199% YTM
Maturity dateSep 18, 2054
Coupon4.70% (Fixed)
6.187% YTM
Maturity dateNov 5, 2045
Coupon5.20% (Fixed)
6.162% YTM
Maturity dateMay 6, 2044
Coupon4.40% (Fixed)
6.159% YTM
Maturity dateNov 20, 2045
Coupon4.00% (Fixed)
6.148% YTM
Maturity dateAug 14, 2050
Coupon2.75% (Fixed)
6.040% YTM
Maturity dateSep 21, 2042
Coupon3.70% (Fixed)
5.826% YTM
Maturity dateMar 18, 2036
Coupon4.90% (Fixed)
5.721% YTM
Maturity dateNov 5, 2035
Coupon4.60% (Fixed)

See all NOT bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.61%
Market value‪4.18 B‬
VEA
Vanguard FTSE Developed Markets ETF
Weight0.85%
Market value‪2.78 B‬
IEFA
iShares Core MSCI EAFE ETF
Weight1.06%
Market value‪2.02 B‬
CHDVD
iShares Swiss Dividend ETF (CH)
Weight15.43%
Market value‪1.53 B‬
EFA
iShares MSCI EAFE ETF
Weight1.24%
Market value‪956.38 M‬
CHSPI
iShares Core SPI(R) ETF (CH)
Weight12.15%
Market value‪850.35 M‬
SMICHA
UBS ETF (CH) - SMI ETF -CHF dis-
Weight15.87%
Market value‪718.89 M‬
SMIA
UBS ETF (CH) - SMI ETF Units -CHF acc-
Weight15.87%
Market value‪718.89 M‬
VGK
Vanguard FTSEEuropean ETF
Weight1.73%
Market value‪682.39 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.67%
Market value‪677.77 M‬
SCHF
Schwab International Equity ETF
Weight0.91%
Market value‪619.95 M‬

Explore more ETFs 

Frequently asked questions


The current price of NOT is 129.32 EUR — it has increased by 1.57% in the past 24 hours. Watch Novartis AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Novartis AG stocks are traded under the ticker NOT.
NOT stock has risen by 5.36% compared to the previous week, the month change is a −2.68% fall, over the last year Novartis AG has showed a 23.16% increase.
We've gathered analysts' opinions on Novartis AG future price: according to them, NOT price has a max estimate of 162.86 EUR and a min estimate of 106.29 EUR. Watch NOT chart and read a more detailed Novartis AG stock forecast: see what analysts think of Novartis AG and suggest that you do with its stocks.
NOT reached its all-time high on Feb 27, 2026 with the price of 144.20 EUR, and its all-time low was 26.44 EUR and was reached on Mar 4, 2009. View more price dynamics on NOT chart.
See other stocks reaching their highest and lowest prices.
NOT stock is 1.21% volatile and has beta coefficient of 0.56. Track Novartis AG stock price on the chart and check out the list of the most volatile stocks — is Novartis AG there?
Today Novartis AG has the market capitalization of ‪231.75 B‬, it has increased by 0.99% over the last week.
Yes, you can track Novartis AG financials in yearly and quarterly reports right on TradingView.
Novartis AG is going to release the next earnings report on Oct 27, 2026. Keep track of upcoming events with our Earnings Calendar.
NOT earnings for the last quarter are 2.11 EUR per share, whereas the estimation was 1.90 EUR resulting in a 11.17% surprise. The estimated earnings for the next quarter are 1.99 EUR per share. See more details about Novartis AG earnings.
Novartis AG revenue for the last quarter amounts to ‪12.62 B‬ EUR, despite the estimated figure of ‪12.33 B‬ EUR. In the next quarter, revenue is expected to reach ‪12.86 B‬ EUR.
NOT net income for the last quarter is ‪2.79 B‬ EUR, while the quarter before that showed ‪2.68 B‬ EUR of net income which accounts for 0.00% change. Track more Novartis AG financial stats to get the full picture.
Yes, NOT dividends are paid annually. The last dividend per share was 4.09 EUR. As of today, Dividend Yield (TTM)% is 3.09%. Tracking Novartis AG dividends might help you take more informed decisions.
Novartis AG dividend yield was 3.38% in 2025, and payout ratio reached 61.77%. The year before the numbers were 3.95% and 67.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 29, 2026, the company has ‪75.27 K‬ employees. See our rating of the largest employees — is Novartis AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novartis AG EBITDA is ‪18.39 B‬ EUR, and current EBITDA margin is 40.92%. See more stats in Novartis AG financial statements.
Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novartis AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novartis AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novartis AG stock shows the buy signal. See more of Novartis AG technicals for a more comprehensive analysis.